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Abstract 
 
This project uses an RNA-based gene expression control system for metabolic engineering of 
Clostridium acetobutylicum. The primary focus is enhancing production of n-butanol, a green 
alternative to fossil fuels. Butanol is an attractive alternative fuel with higher energy density than 
other biofuels, and can directly replace gasoline. To improve the production of butanol using 
Clostridium, a small RNA (sRNA) platform is utilized. RNA is useful as a genetic regulatory 
tool because it provides flexible expression tuning compared to the on/off DNA knockout 
method. sRNAs are used by bacteria for regulating gene expression, as they bind to protein-
coding mRNA sequences. Through binding, sRNA can enhance or reduce mRNA translation and 
thus protein expression. Two genes in the metabolic pathway, buk and hydA, will be down 
regulated using sRNA, potentially increasing butanol titer and yield without compromising cell 
growth.  Down-regulation of these genes presents a novel opportunity to modify Clostridium, as 
hydA is essential to cellular function and cannot be completely turned off. Furthermore, using 
sRNA allows for simultaneous targeting of both genes. This is done using genetic engineering 
techniques to transform wild type cells with the desired genes. The recombinant plasmid for 
sRNA production is derived from E. coli and then ported over. Mutants are then screened and 
tested to determine performance as compared to the original strain. One mutant and a control 
plasmid have been successfully transformed. Preliminary results show that the mutant targeting 
hydA successfully down regulates the gene and reduces production of butyric acid, while also 
increasing butanol production. This project could have significant contribution to improving 
economic viability of biologically derived n-butanol. Furthermore, the sRNA platform has 
potential for broad applications in metabolically engineering various bacterial species. 
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Chapter 1: Introduction 
 
1.1 Backgrounds and Motivation 
Consumer consumption of gasoline in the United States totals 384.74 million gallons per 
day. Due to its nonrenewable status, damaging environmental impacts, and trade requirements, 
alternative fuels are under active development. One such fuel is biobutanol. This four-carbon 
alcohol is fermentatively derived from biological carbon sources like sugarcane, cassava, and 
wheat 
[1]
. Biologically produced n-butanol (bio-butanol) displays potential as a gasoline 
alternative, sharing many key traits and being directly usable in cars and pipelines without 
infrastructure changes. Currently, ethanol can be blended at up to 85% volume as a gasoline 
substitute, but butanol can fully replace gasoline with less performance trade-offs in 
conventional combustion engines 
[1]
. Butanol has 87% of the energy content of gasoline, 
compared to only 67% for ethanol 
[14, 16]
. Furthermore, bio-butanol has industrial applications as 
a chemical feedstock, solvent, lubricant and diluent 
[1, 2, 4]
.  
The foremost microbe used in fermentative butanol production is Clostridium 
acetobutylicum. This is a gram-positive, spore-forming, rod-shaped, obligate anaerobe. 
Furthermore, it is capable of utilizing a wide variety of carbon sources to grow, and produce 
metabolites. Fermentation of butanol using the Acetone-Butanol-Ethanol (ABE) metabolic 
pathway in C. acetobutylicum is a well-understood process. This fermentation has been used 
industrially since 1916, and was first discovered in the late 1800’s by Louis Pasteur [14]. For 
example, in the Second World War, C. acetobutylicum was used to produce acetone for use in 
explosives 
[2]
. Other microbial systems are being researched for potentials use in producing this 
biofuel, but thus far Clostridium remains the most promising means of doing so 
[1, 2]
.   The ABE 
fermentation pathway in C. acetobutylicum is shown in Figure 1. This pathway consists of two 
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phases: acidogenic and solventogenic. The acidogenic phase has acid production (acetate and 
butyrate), with ATP formation and hydrogen evolution. Acid production reduces external pH, 
and triggers the solventogenic phase. This phase produces the pathway’s namesake solvents 
acetone, butanol, and ethanol in a 3:6:1 ratio
 [1,5,7]
. Regulation of this pathway is complex. C. 
acetobutylicum produces butanol through the alcohol-aldehyde dehydrogenase (AAD) and AAD2 
enzymes, expressed by the genes adhE and adhE2 
[7]
. In the wild type microbe, C. 
acetobutylicum ATCC 824, butanol production reaches about 10.3 g/L via the solventogenic 
phase, while acidogenic fermentation can produce up to 5.5 g/L 
[7, 8]
. Butanol is produced by 
enzymatic transformation of butyryl-CoA into butanol, as ethanol is transformed from acetyl-
CoA. Metabolite production is found primarily in the stationary phase. Butyrate, is produced via 
expression of the buk gene, which directly competes for carbon flux with butanol production 
[3]
.  
While the Clostridia butanol fermentation pathway is well understood, there are several 
barriers to the economic feasibility of bio-butanol: substrate costs, titer/selectivity, and recovery 
costs
 [1, 2, 4]
. Currently, biobutanol has a market price of $7.94 per gallon vs. ~ $2.00 per gallon 
gasoline. Production costs for biobutanol range from one to three dollars per gallon 
[15]
. To 
reduce production costs, yield and selectivity must be increased. Conventional metabolic 
engineering strategies have shown successful application towards this goal 
[6-12]
. Metabolic 
engineering typically involves gene manipulation through addition, deletion, or over-expression 
in a pathway. While metabolic engineering techniques are easily applied in well-understood 
bacteria like E. coli, Clostridia lack the genomic background for easy genetic manipulation. 
Attempts to knock out acidogenic pathways that produce byproducts have not fully succeeded. 
While single knock out attempts have succeeded 
[2]
, double knockouts targeting multiple genes 
have failed, since the pathways are important to ATP production and cell health
 [11, 12]
. This is 
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especially relevant in concerning the hydA gene, which is expressed in hydrogenase production, 
and is essential to microbe survival. Previous attempts to knock-out this gene have proven 
unsuccessful 
[11. 12]
.  
Small regulatory RNA (sRNA) is universal in bacteria for regulation of gene expression. 
These are complex polymers that base pair with messenger RNA (mRNA). Normally, DNA 
encodes genes that are transcribed to mRNA. This is then translated to proteins. But, when sRNA 
binds mRNA, protein synthesis can be prevented. In E. coli, DsrA sRNA (DsrA) has tertiary 
structure in the form of stem-loops, and is used in activation of rpoS and hns translation 
[3]
. See 
more about the DsrA in Figure 2. The DsrA has three loops in its stem, with the relevant 
sequences on the first two. It is dual acting; modifying the code of one of the stem loops can 
produce synthetic sRNA variants, which are re-targeted as desired. Since we can modify two 
loops, we can thus target two genes: hydA and buk. As mentioned, these genes regulate the 
hydrogen and butyrate production pathways, respectively, as seen in Figure 1.  
  sRNA regulation provides a more flexible and tunable alternative to knocking out DNA 
genes. Advantages of using this tool include portable and cost efficient control of the pathways, 
as well as circumvention of tampering with the host chromosomal DNA. The sRNA can be used 
to target mRNA used for translating the fermentative enzymes used in a metabolic pathway of 
interest. Thus, down-regulation presents an intriguing alternative to completely eliminating 
undesirable side reactions or components of a metabolic pathway 
[3]
. Post-transcriptional tuning 
of gene expression for hydA and buk can enhance titer by directing carbon flux through the ATP 
and butanol production pathways. This has a dual effect of reducing side reactions and increasing 
the primary reaction. 
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1.2 Problem Statement 
Improving yield and selectivity of the fermentative process is a challenging problem. The 
goal of this project is to increase these in C. acetobutylicum by targeting the hydA and buk genes 
using an sRNA based metabolic engineering tool.  This project also seeks to demonstrate the 
effectiveness of this tool as a platform that can be easily used across differing microbes. The 
platform can circumvent the present conundrum of deactivating vital genes, and also provide a 
flexible, simpler method to act on dual-targets within a microbe. The effectiveness of retargeting 
the DsrA stem loop will be tested for three different targets: hydA expression, buk expression, 
and both hydA and buk gene expression. Each of these will be tested for enhanced butanol 
production at different concentrations of this sRNA in C. acetobutylicum, as compared to the 
ATCC 824 wild type, using the native E. coli DsrA, and current standards of butanol production.  
 
1.3 Organization 
 Chapter two of this thesis discusses the materials and methods used in executing the 
project. In Chapter three, results and discussion, as well as setbacks and are discussed. Chapter 
four provides a summary and conclusion, as well as suggestions for future work. Figures are 
placed at the end of each appropriate section.  
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Figure 1: C. acetobutylicum Metabolic Pathway 
[19]
 
Enzymes are shown with arrows. Acid and solvent fermentations are shown in red and blue 
respectively. Acetate and butyrate pathways comprise the acid production. The hydrogen 
pathway is regulated by hydA (essential). An enzyme generates NADH from NAD, which is 
favored when this pathway is blocked. Acid production detracts from butanol synthesis and 
selectivity. The hydrogen pathway also consumes NADH required for butanol production. 
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Figure 2: sRNA Scaffold Design 
[18]
 
The RNA loops on itself three times, due to complementary sequences. Here are shown three 
variants with a) being retargeted for buk, b) being retargeted for hydA, and c) having both targets. 
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Chapter 2: Methodology  
 
2.1 Bacterial Strains and Plasmids 
In order to perform this experiment, two strains of E. coli were required, and Clostridium 
acetobutylicum ATCC 824 was used. Plasmid amplification was performed using the E. coli 
strain CA434, graciously provided by Dr. Yang’s laboratory. Constructed vectors were 
transformed into CA434 using heat shock transformation. Subsequent methylation of the plasmid 
was undertaken in E. coli strain pAN2, also provided by Dr. Yang’s laboratory. This was then 
used to transform the final vector in C. acetobutylicum ATCC 824. All E. coli cells were grown 
aerobically in LB medium (LB Broth, Miller R453642) with shaking in a rotary shaker, at 37°C. 
Clostridium acetobutylicum was grown in clostridial growth medium (CGM). Strains were 
retained via 15% Glycerol stocks constructed and stored at -80°C for up to eight months.  
Furthermore, the construction of several plasmids was necessary. Plasmid construction 
will not be discussed in this work, as Ashwin Lahiry undertook this. Several initial plasmids 
have been constructed for use in proof of concept work. Proof-of-concept plasmids are pAL001 
(containing a hydA targeting DsrA), pALDsrA (containing the native E. coli DsrA), and have 
pMTL85151 as the control plasmid for transformation into Clostridium. These vectors were 
designed for use in either electroporation or conjugation into C. acetobutylicum. Features of 
interest include the ORF H gene for plasmid replication within C. acetobutylicum, ColE1 for 
plasmid replication in E. coli, catP for thiamphenicol resistance, and traJ for E. coli conjugation. 
Plasmid maps can be found in Figure 3. A list of strains and plasmids is provided in Table 1, 
Appendix A.  
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2.2 Transformation Methods 
2.21 Heat Shock 
Heat shock transformation was executed using 50 μL of CA434 cells, and 10 μL of 
ligation product. These were cooled to 4°C, mixed and held on ice for 30 minutes. Subsequently, 
the mixture was placed in a 42°C water bath for one minute, and then returned to ice for five 
minutes. The mixture was then regenerated in 240 μL of SOC medium (Invitrogen 15544-034) 
and held for 60 minutes at 37°C and 250 rpm. The mixture was then spread onto plates having 
cycloserine as a selective agent. All cell exposure to air was performed near a flame to ensure 
sterility.  
 
2.22 Electroporation 
C. acetobutylicum ATCC 824 cells were grown in 50 mL serum bottles in CGM to mid-
log phase, based on an OD600 of 0.6. These were inoculated using a 2.5 mL seed culture grown 
overnight in an anaerobic test tube containing 5 mL CGM, inoculated with 250 μL of a culture 
regenerated from 15% glycerol stock and grown overnight to OD600 of 2-3. Cells were harvested 
via centrifugation at 2200g, for 10 minutes at 4°C. The cells were then resuspended and washed 
in a total of 60 mL ETM buffer (270 mM saccharose, 0.6 mM Na2HPO4, 4.4 mM NaH2PO4, 10 
mM MgCl2). This suspension was centrifuged for 10 minutes at 2200g, again at 4°C. The 
resulting pellet was resuspended in total 1.5 mL ET buffer (270 mM saccharose, 0.6 mM 
Na2HPO4, 4.4 mM NaH2PO4). Electroporation cuvettes (0.1 cm inter-electrode distance) were 
placed on ice for 15 minutes, before adding 400 μL cells, and 10 μL (400 ng/μL) of recombinant 
DNA plasmid. Cuvettes were held on ice for another 15 minutes, before performing 
electroporation. Electroporation was performed using 2kV voltage, 200 Ohms resistance, and 25 
μF capacitance (Bio-Rad Gene Pulser). Resulting time constant values were kept under 3 msec. 
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After electroporation, cuvettes were immediately returned to ice for 10 minutes. Subsequent 
regeneration in 1 mL of liquid CGM was performed at 37°C until bubbles indicated growth (4 – 
12 hours).  Then, 3 mL of liquid CGM with thiamphenical (15 μL/mL final concentration) was 
added. This was grown at 37°C for 12 hours, or until substantial growth was observed. Resulting 
cells were confirmed as described in 2.3, before being stored at -80°C in 15% glycerol stock 
solutions. All electroporation steps were performed anaerobically using an anaerobic chamber.  
 
2.23 Conjugation 
C. acetobutylicum ATCC 824 cells were grown in 5 mL liquid CGM at  37°C using a 
anaerobic tubes at OD600 of 2-3, inoculated with 250 μL of a culture regenerated from 15% 
glycerol stock and grown overnight to OD600 of 2-3. E. coli CA434 cells harboring recombinant 
plasmids were grown in liquid LB medium containing 30 mg/L chloramphenicol at 37°C and 
250 rpm to reach OD600 of 1.5–2.0. 3 mL of donor CA434 cells were centrifuged at 4000f doe 2 
minutes before being resuspended and washed using 1 mL of sterile phosphate-buffered saline 
(PBS). This as mixed with 0.4 mL of recipient ATCC 824 cells, and spotted onto well-dried 
CGM agar plates using a pipette. Plates were then incubated at 37°C for 24 hours to allow 
conjugation to occur. After 24 hours, 1 mL CGM was applied to each plate to harvest cells. 
Harvested cells were resuspended and spread onto CGM plates containing 45 mg/mL 
thiamphenicol and 250 mg/mL cycloserine as selective agents. Plates were incubated for 2-3 
days to allow colony growth, and positive transformants were then confirmed as described in 2.3, 
before being stored at -80°C in 15% glycerol stock solutions. All conjugation steps were also 
performed in an anaerobic chamber.  
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2.3 Mutant Confirmation 
Mutant confirmation was done using colony PCR screening and plasmid extraction. 
Colonies were added to a PCR reaction using the appropriate Taq polymerase and primers. 
Resulting DNA products were confirmed using gel electrophoresis.  
DNA was extracted by mini prep, as follows. 2 mL culture was centrifuged at 10,000g for 10 
minutes. The pellet was resuspended in 200 μL P1 buffer, and 10 μL lysozyme added. The 
mixture was held at 37°C for 20 minutes. Then 250 μL P2 buffer was added, the solution gently 
mixed and let sit for 5 minutes. 350 μL N3 buffer was added and solution centrifuged at 21,000g 
for 5 minutes. The solution was then transferred to a filter, and centrifuged for 2 minutes at 
6,000g. A 700 μL silica wash was added, and centrifuged at 10,000g for 1 minute. The pass 
through was discarded and filter centrifuged again at the same settings. 30 μL de-ionized water 
was added and let stand for 1 minute before centrifuging at 10,000g for 5 minutes. The pass 
through was recycled and centrifuged again at the same settings. Resulting DNA was then sent 
for final confirmation via sequencing.  
 
2.4 Fermentation 
 Fermentation kinetics were studied using serum bottles. 125 mL serum bottles were 
prepared with 50 mL CGM, and purged to anaerobic condition using N2 for a time period of 10 
minutes. These were inoculated using 2.5 mL of a seed culture grown overnight in an anaerobic 
test tube having 5 mL of CGM, inoculated with 250 μL stock culture regenerated from 15% 
glycerol and grown overnight to OD600 of 2-3. Fermentation broth was sampled at 12 hour 
intervals, using 1-mL syringes, checked for OD600 and pH and centrifuged for 15 minutes at 
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12,800 rpm. The supernatant was collected and stored at -20°C for future analysis. All 
fermentative runs were performed in triplicate.  
 
2.5 Analytical Methods  
Cell density was measured using a spectrophotometer (UV-16-1, Shimadzu, Columbia, 
MD), at 600 nm. Glucose values were analyzed using a high-performance liquid chromatograph 
(HPLC, LC-20AD, Shimadzu, Columbia, MD) equipped with an HPC-87H organic acid analysis 
column (Bio-Rad) at 65°C, with 0.6 mL/min, 5mM H2SO4 as the mobile phase, as described 
elsewhere 
[2]
. A gas chromatograph (GC-2014 Shimadzu, Columbia, MD) equipped with a flame 
ionization detector (FID) and a 30.0 m fused silica column (Stabilwax-DA, 0.25 mm film 
thickness and 0.25 mm ID, Restek, Bellefonte, PA) was used to analyze butanol, ethanol, 
acetone, acetate, and butyrate values. The GC was run at an injection temperature of 200°C with 
1 μL of sample injected using an auto injector (AOC-20i, Shimadzu). Column temperature was 
held at 80°C for 3 minutes, increased at 30°C/min to 150°C, and held at 150°C for 3.7 minutes.  
Furthermore, enzyme activity assays were used to determine level of sRNA expression within 
fermentation cultures.  
2.6 Statistical Analysis 
Average values from triplicate bottles were calculated and reported. 
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Chapter 3: Results and Discussion 
 
3.1 Roadblocks and Troubleshooting 
Although transformation of C. acetobutylicum has a demonstrated history of success and 
should be trivial, initial attempts to transform our plasmids into Clostridium were unsuccessful. 
There have been many unexpected challenges. First, electroporation results were showing odd 
sized DNA results from colony PCR, not appropriate to the sizes expected for our recombinant 
DNA plasmids. Eventually, it was found that our ATCC 824 stock was impure, having some 
plasmid already within it. This also had the unfortunate effect of conferring antibiotic resistance 
to our control/recipient strain. Upon determination of this, a fresh strain was ordered from 
ATCC. The first strain we received was nonproductive and had to be replaced. Having fixed our 
stock ATCC 824 issue, we determined that the agar present in reinforced clostridial media 
(RCM) was preventing proper purification of cells from medium components during 
electroporation preparation steps. This caused electroporation cuvettes to be burst, and reduced 
successfulness of the transformation.  Upon switching to CGM media, initial attempts at C. 
acetobutylicum culture were met with perplexing unsuccessfulness, and we determined that the 
type of tryptone and yeast extract used were not appropriate quality for use in CGM.  Issues with 
anaerobic chamber integrity have also set back progress and complicated transformation.   
 
3.2 Metabolic Engineering Results 
Plasmids have been constructed, and verified in E. coli. The pAL001, pALDsrA, and 
pMTL85151 plasmid maps are shown in Figures 3 - 5. Currently, pAL001 and pMTL85151 
plasmids have been successfully transformed into C. acetobutylicum ATCC 824. These mutants 
are referred to as C. acetobutylicum pAL001 and C. acetobutylicum pMTL85151, respectively. 
13 
 
Sequencing has shown that the pAL001 mutants are a mixed population, with some having lost 
part or all of their synthetic sRNA sequence conferring hydA regulation.    
 
3.3 Fermentation Results  
Exploratory fermentation was performed to compare C. acetobutylicum pAL001 to 
ATCC 824, using serum bottles run in triplicate for 60 hours. Fermentation data from the first 
run differed from those of the second two, so all data is reported based on the duplicates. Data 
tables are attached in Tables 2 and 3, in Appendix B. As seen in Figures 6 & 7, the pAL001 
mutant significantly outperforms ATCC 824 in regards to both butanol and butyrate production. 
pAL001 produces ~0.45 g/L butanol vs. 0.05 /L in ATCC 824. This is almost 10-fold 
improvement. Furthermore, butyrate production is severely reduced: 0.01 g/L vs. 0.27 g/L. 
Reduction is 27-fold. Data must be considered in light of ATCC 824 having acid crashed during 
these studies. That is, pH values were below optimal for solventogenesis. Comparison of other 
solvents production also produced interesting results. While ethanol production was 
approximately equal between both strains, acetone production was improved four fold in 
pAL001. It produced ~0.2 g/L acetone compared to ~0.05 g/L in ATCC 824. Acetic acid 
production was unchanged from the wild type strain.  
Both strains reached OD600 of 5.5, but the wild type strain had a longer lag time before the log 
phase: 20 hours vs. 10 hours in the mutant strain. Figures showing discussed comparisons are 
given in Appendix C.  
Unfortunately, neither strain performed as expected, faring far worse than literature 
values show the wild type being capable of achieving. Furthermore, pH shift experienced was 
inconsistent between the two strains, with the wild type seeming to have remained in the 
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acidogenic phase, causing acid crash and preventing entry into solventogenesis. The mutant 
strain demonstrated superior pH regulation, switching from acid production to solvent production 
earlier relative to the control. Furthermore, neither strain seemed to consume much glucose, 
having only used 20 g/L equivalent over the course of a 60-hour fermentation. These 
complications can be attributed to the serum bottle fermentations being performed in CGM, 
rather than one designed for metabolite production like P2 medium. This was done due to a lack 
of the necessary medium components to produce P2. Even so, the total productivity of carbon 
conversion to metabolites was much lower than expected.  
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Figure 3: pMTL85151 Plasmid Map. 
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Figure 4: pAL001 Plasmid Map. 
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Figure 5: pALDsrA Plasmid Map. 
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Figure 6: Comparison of Butanol Production between pAL001 Mutant and ATCC 824 Control 
Strain. 
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Figure 7: Comparison of Butyrate Production between pAL001 Mutant and ATCC 824 Control 
Strain. 
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Chapter 4: Conclusions & Recommendations 
 
4.1 Conclusions 
Butanol is a promising alternative fuel that can directly replace gasoline in current 
infrastructure. The major impediment to butanol utilization is high production costs, primarily 
stemming from low yield and selectivity in fermentation. Standard metabolic engineering 
practices have demonstrated some effectiveness in improving the C. acetobutylicum production 
of butanol, but have not managed to achieve economic feasibleness. One major problem is the 
targeting of organism essential genes, such as hydA. Since these cannot be knocked out, there is 
little that can be done to redirect carbon flux to desirable pathways. Furthermore, construction of 
double knock-outs is a time consuming and nontrivial process. We have developed an sRNA 
gene expression control system is a promising metabolic engineering tool, which provides a 
finessed alternative to the classical knockout technique. This both allows targeting of essential 
genes, previously inaccessible for metabolic tuning, and also an easy platform to construct dual-
targeting mutants.  
 Preliminary data shows that our single target mutant strain outperforms the wild type, albeit both 
strains performed quite poorly in the initial fermentation.  
 
4.2 Recommendations 
The mutant pAL001 strain is currently being purified to ensure a pure population before 
moving forward with further fermentation and assays to quantify its performance. In light of 
poor performance from both pAL001 and ATCC 824 in CG, fermentation should be repeated in 
the appropriate P2 medium. Furthermore, all constructed mutants are being ported over to the 
pMTL82151 plasmid, which has better compatibility and ease of insertion into ATCC 824. 
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Further mutants are also currently being transformed into Clostridium to test their effect when 
targeting the buk gene and using the native E. coli variant. As well, work is being done to 
transform the dual acting sRNA into Clostridium, as this is the best outcome mutant being 
explored by this project.  
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Appendix A: List of Strains and Plasmids. 
 
 
 
 
Table 1: List of Strains and Plasmids. 
STRAINS 
C. acetobutylicum E. coli 
ATCC 824 (Wild Type) CA434 (plasmid amplification strain) 
pAL001 (hydA targeting mutant) pAN2 (methylation strain) 
pALDsrA (native E. coli DsrA mutant)  
pMTL85151 (control transformed mutant)  
PLASMIDS 
pAL001 (hydA targeting plasmid constructed using pMTL85151) 
pALDsrA (native E. coli targeting plasmid constructed using pMTL85151) 
pMTL85151 (Original Base Plasmid) 
pMTL82151 (New Base Plasmid) 
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Appendix B: Serum Bottle Data Tables. 
 
 
 
 
 
Table 2: Fermentation Data for pAL001 Mutant. 
Time (hrs) 0 12.75 17 21.75 24 37.58 47 
Acetone (g/L) 0.008065 0.063641 0.10206 0.121275 0.159715 0.198425 0.198155 
Ethanol (g/L) 0.0103 0.014575 0.01443 0.01729 0.000215 0.00025 0.000245 
Butanol (g/L) 0.007355 0.14628 0.23123 0.324365 0.338245 0.427935 0.428815 
Acetate (g/L) 0.210295 0.188035 0.17876 0.1661 0.138325 0.126115 0.122915 
Butyrate 
(g/L) 0 0.00693 0.00606 0.00603 0.00486 0.01147 0.01164 
OD 1.045 3.4 4.875 5.4 5.81 5.69 5.31 
pH 6.22 4.925 4.93 5.15 4.85 4.83 4.805 
Glucose (g/L)  62.74583647 
39.88660
139 
38.70951
544 
34.10620
136 
32.03950
121 
29.54347
644 
28.59067
704 
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Table 3: Fermentation Data for ATCC 824 Control. 
Time (hrs) 0 12.75 17 21.75 24 37.58 47 
Acetone (g/L) 0.00508 0.00422 0.00584 0.00315 0.00508 0.05134 0.04972 
Ethanol (g/L) 0.01363 0.01037 0.00565 0.00693 0.00011 0.00016 0.00016 
Butanol (g/L) 0 0 0 0 0 0.06554 0.06281 
Acetate (g/L) 0.22784 0.23455 0.17786 0.19898 0.15484 0.15761 0.14945 
Butyrate 
(g/L) 0.02742 0.0179 0.01284 0.03215 0.09385 0.28836 0.27104 
OD 0.51 0.53 0.55 1.01 2.14 5.41 4.9 
pH 5.6 6.08 6.16 5.17 4.28 3.72 3.75 
Glucose (g/L)  62.76675872 
56.32270
483 
45.00795
046 
34.76441
543 
34.87237
426 
32.62197
673 
27.32697
297 
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Appendix C: Fermentation Data Figures.  
 
 
 
 
 
 
Figure 8: Comparison of Acetone Production. 
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Figure 9: Comparison of Ethanol Production. 
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Figure 10: Comparison of Butanol Production. 
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Figure 11: Comparison of Acetate Production. 
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Figure 12: Comparison of Butyrate Production. 
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Figure 13: Comparison of Cell Growth. 
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Figure 14: Comparison of Fermentation pH. 
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Figure 15: Comparison of Glucose Consumption. 
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